AZN – AstraZeneca PLC
Astrazeneca PLCAZN
$74.22Name : Astrazeneca PLC
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $230,102,794,240.00
EPSttm : 2.25
Astrazeneca PLC
$74.22
0.97%$0.71Float Short %
0.55
Margin Of Safety %
8
Put/Call OI Ratio
0.4
EPS Next Q Diff
0.1
EPS Last/This Y
EPS This/Next Y
0.57
Price
74.21
Target Price
86.96
Analyst Recom
1.45
Performance Q
17.08
Relative Volume
0.66
Beta
0.43
Ticker: AZN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-24 | AZN | 69.06 | 0.53 | 0.10 | 125169 |
| 2025-01-27 | AZN | 69.99 | 0.54 | 1.91 | 126116 |
| 2025-01-28 | AZN | 69.61 | 0.58 | 0.07 | 131356 |
| 2025-01-29 | AZN | 70.24 | 0.52 | 0.27 | 140625 |
| 2025-01-30 | AZN | 71.23 | 0.50 | 0.37 | 148714 |
| 2025-01-31 | AZN | 70.77 | 0.50 | 0.10 | 150256 |
| 2025-02-03 | AZN | 69.86 | 0.51 | 0.41 | 141431 |
| 2025-02-04 | AZN | 68.97 | 0.50 | 0.92 | 144597 |
| 2025-02-05 | AZN | 70.93 | 0.51 | 0.32 | 148834 |
| 2025-02-06 | AZN | 72.41 | 0.47 | 0.13 | 166973 |
| 2025-02-07 | AZN | 72 | 0.42 | 0.62 | 186568 |
| 2025-02-10 | AZN | 72.65 | 0.41 | 0.07 | 179668 |
| 2025-02-11 | AZN | 72.72 | 0.38 | 0.12 | 191475 |
| 2025-02-12 | AZN | 74.45 | 0.38 | 0.36 | 195067 |
| 2025-02-13 | AZN | 74.42 | 0.39 | 0.21 | 195015 |
| 2025-02-14 | AZN | 73.59 | 0.38 | 0.11 | 205802 |
| 2025-02-18 | AZN | 74.79 | 0.39 | 0.07 | 200205 |
| 2025-02-19 | AZN | 73.81 | 0.37 | 0.12 | 210978 |
| 2025-02-20 | AZN | 74.57 | 0.36 | 0.01 | 212192 |
| 2025-02-21 | AZN | 74.22 | 0.40 | 0.44 | 200861 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-24 | AZN | 69.07 | 50.9 | 5617.2 | 4.15 |
| 2025-01-27 | AZN | 70.08 | 50.9 | 5769.2 | 4.15 |
| 2025-01-28 | AZN | 69.60 | 50.9 | 5401.8 | 4.15 |
| 2025-01-29 | AZN | 70.23 | 50.9 | 5532.8 | 4.15 |
| 2025-01-30 | AZN | 71.24 | 50.9 | 5674.2 | 4.15 |
| 2025-01-31 | AZN | 70.76 | 48.1 | 5334.6 | 4.15 |
| 2025-02-03 | AZN | 69.86 | 48.1 | 5163.7 | 4.15 |
| 2025-02-04 | AZN | 68.95 | 48.1 | 5052.8 | 4.15 |
| 2025-02-05 | AZN | 70.93 | 48.1 | 5716.2 | 4.15 |
| 2025-02-06 | AZN | 72.36 | 48.1 | 5824.6 | 4.15 |
| 2025-02-07 | AZN | 72.01 | 48.1 | 5048.7 | 4.15 |
| 2025-02-10 | AZN | 72.66 | 48.1 | - | 4.64 |
| 2025-02-11 | AZN | 72.72 | 48.1 | - | 4.49 |
| 2025-02-12 | AZN | 74.45 | 48.1 | - | 4.49 |
| 2025-02-13 | AZN | 74.43 | 48.1 | - | 4.49 |
| 2025-02-14 | AZN | 73.58 | 48.1 | - | 4.47 |
| 2025-02-18 | AZN | 74.79 | 5.6 | - | 4.47 |
| 2025-02-19 | AZN | 73.81 | 5.6 | - | 4.47 |
| 2025-02-20 | AZN | 74.57 | 5.6 | 5239.0 | 4.47 |
| 2025-02-21 | AZN | 74.21 | 5.6 | 5559.4 | 4.47 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-24 | AZN | 0.00 | -0.47 | 0.41 |
| 2025-01-27 | AZN | 0.00 | -0.48 | 0.41 |
| 2025-01-28 | AZN | 0.00 | -0.48 | 0.49 |
| 2025-01-29 | AZN | 0.00 | -0.48 | 0.49 |
| 2025-01-30 | AZN | 0.00 | -0.48 | 0.49 |
| 2025-01-31 | AZN | 0.00 | -0.48 | 0.49 |
| 2025-02-03 | AZN | 0.00 | -0.47 | 0.49 |
| 2025-02-04 | AZN | 0.00 | -0.47 | 0.49 |
| 2025-02-05 | AZN | 0.00 | -0.47 | 0.49 |
| 2025-02-06 | AZN | 0.00 | -0.47 | 0.49 |
| 2025-02-07 | AZN | 0.00 | -0.47 | 0.49 |
| 2025-02-10 | AZN | 0.00 | -1.72 | 0.49 |
| 2025-02-11 | AZN | 0.00 | -1.72 | 0.49 |
| 2025-02-12 | AZN | 0.00 | -1.72 | 0.55 |
| 2025-02-13 | AZN | 0.00 | -1.72 | 0.55 |
| 2025-02-14 | AZN | 0.00 | -1.72 | 0.55 |
| 2025-02-18 | AZN | 0.00 | -1.67 | 0.55 |
| 2025-02-19 | AZN | 0.00 | -1.67 | 0.55 |
| 2025-02-20 | AZN | 0.00 | -1.67 | 0.55 |
| 2025-02-21 | AZN | 0.00 | -1.67 | 0.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.05
Avg. EPS Est. Current Quarter
1.09
Avg. EPS Est. Next Quarter
1.15
Insider Transactions
Institutional Transactions
-1.67
Beta
0.43
Average Sales Estimate Current Quarter
13754
Average Sales Estimate Next Quarter
14104
Fair Value
80.24
Quality Score
91
Growth Score
99
Sentiment Score
84
Actual DrawDown %
15.4
Max Drawdown 5-Year %
-27.9
Target Price
86.96
P/E
32.93
Forward P/E
14.66
PEG
2.95
P/S
4.26
P/B
5.64
P/Free Cash Flow
22.39
EPS
2.25
Average EPS Est. Cur. Y
4.47
EPS Next Y. (Est.)
5.04
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.01
Relative Volume
0.66
Return on Equity vs Sector %
-2
Return on Equity vs Industry %
-9.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.29
EBIT Estimation
5559.4
Astrazeneca PLCSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading